1 active not recruiting, 1 completed, 1 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Completed 1, Terminated 1 |
Follow Chronic Atrophic Gastritis: new trials by email Literature Review of Chronic Atrophic Gastritis trials Research Report on Chronic Atrophic Gastritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia Curcumin, Laboratory Biomarker Analysis, Placebo Administration - Chronic Atrophic Gastritis, Gastric Carcinoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 50 | 2017-04-04 | 2026-09-14 |
| YF476 and Type I Gastric Carcinoids (Norway) YF476 - Chronic Atrophic Gastritis, Hypergastrinemia | Phase 2 | Terminated | Trio Medicines Ltd. | 8 | 2011-06-01 | 2015-05-15 |
| YF476 and Type I Gastric Carcinoids YF476 - Chronic Atrophic Gastritis, Hypergastrinaemia | Phase 2 | Completed | Trio Medicines Ltd. | 8 | 2011-01-04 | 2019-08-19 |
Gastritis, Atrophic (3) · Stomach Neoplasms (1)
Digestive System Diseases (3) · Gastritis (3) · Gastroenteritis (3) · Gastrointestinal Diseases (3) · Stomach Diseases (3) · Digestive System Neoplasms (1) · Gastrointestinal Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1)
Trio Medicines Ltd. (2) · National Cancer Institute (NCI) (1)
Honduras (1) · Norway (1) · Puerto Rico (1) · United Kingdom (1)
Malcolm Boyce, BSc FRCP FFPM (2) · Helge Waldum, MD PhD (1) · Marcia R Cruz-Correa (1) · Mark Pritchard, PhD FRCP (1)
PMID 24098507, PMID 39148307, PMID 42077070
N01CN00042 (1), P30CA015083 (1)